IL6 and neoplasm: A study in 2011 revealed that IL-6 is essential in converting non-stem cancer cells to CSCs in human prostate and breast cell lines, and that CSCs express and release naturally higher levels of IL-6 than their non-stem counterparts, thus promoting tumor aggressiveness [73].